Premium Information is available for this item - Upgrade for $1 a day
6505-01-594-6041
Sodium Hyaluronate Injection
6505015946041 015946041 HYLAN G-F 20 HYLAN G-F 20 6ML SYNVISC-ONE SYN0277M 3336625 HILANO G-F 20
January 2023
8
Marketplace 6505-01-594-6041
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-594-6041 5+ Documents (More...)
6505-01-594-6041 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-594-6041
/fsg-65/fsc-6505/us 6505-01-594-6041 /fsg-65/fsc-6505/us 6505-01-594-6041 -65/fsc-6505/us 6505-01-594
6ML SYNVISC-ONE SYN0277M 3336625 HILANO G-F 20 Managed by United States NSN Created https//www.nsnlookup.com
Sodium Hyaluronate Injection 6505015946041 Upgrade your Account Upgrade 6505-01-594-6041Sodium
Sodium Hyaluronate Injection 6505015946041 6041Sodium Hyaluronate Injection6505015946041 015946041
HYLAN G-F 20 HYLAN G-F 20 6ML SYNVISC-ONE SYN0277M 3336625 G-F 20HYLAN G-F 20 6MLSYNVISC-ONESYN0277M3336625
594-6041 us 6505-01-463-5757 Sodium Hyaluronate https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-594-6041
Sodium Hyaluronate Injection 6505015946041 1 | CRITICALITY : X | HMIC : P | PMIC : A | EDC https
Sodium Hyaluronate Injection 6505015946041 65050155463176505-01-554 -6317 -65/fsc-6505/us 6505-
119-9439 6505-01-293-7099 6505-33-003-8713 6505-13-119-8646 6505-27-013-5629 6505-01-554-6317 6505-01-594-6041
Restrictions 6505-01-594-6041
6505-01-594-6041 is a Sodium Hyaluronate Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6505-01-594-6041
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-594-6041
- Brazil (YA01)
- Effective Date:
- 1 Jul 2013
- Belgium (ZB01)
- Effective Date:
- 1 Apr 2011
- United Kingdom (ZK01)
- Effective Date:
- 1 Feb 2016
Approved Sources 6505-01-594-6041
- Part Number
- Manufacturer
- Status
- HYLAN G-F 20 6ML
- Manufacturer
- 08HP7 - Esoterix Genetic Laboratories Llc (Active)
- Primary Buy
- Primary Buy
- HYLAN G-F 20
- U1435 - Sanofi-Aventis Holdings Ltd (Active)
- Incomplete Secondary Reference
- Incomplete Secondary Reference
- SYNVISC-ONE
- U1435 - Sanofi-Aventis Holdings Ltd (Active)
- Secondary Buy
- Secondary Buy
- SYNVISC-ONE
- 08HP7 - Esoterix Genetic Laboratories Llc (Active)
- Secondary Buy
- Secondary Buy
- SYN0277M
- U0085 - Aah Pharmaceuticals Ltd (Active)
- Secondary Buy
- Secondary Buy
- 3336625
- U1435 - Sanofi-Aventis Holdings Ltd (Active)
- Secondary Buy
- Secondary Buy
- HILANO G-F 20
- 015TK - Genzyme Do Brasil Ltda (Obsolete)
- Canceled/Obsolete
- Canceled/Obsolete
Datasheet 6505-01-594-6041
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Administration [CSGS]
- Intra-Articular
- Primary Container Type [CQCT]
- Syringe
- Primary Container Content Quantity [CRLK]
- 10.0 Milliliters
- Features Provided [CBBL]
- Sterile
NATO Stock Numbers Related to 6505-01-594-6041
Freight Information 6505-01-594-6041
6505-01-594-6041 has freight characteristics.. 6505-01-594-6041 has a variance between NMFC and UFC when transported by rail and the description should be consulted.